|
1
|
Cannistra SA: Cancer of the ovary. N Engl
J Med. 351:2519–2529. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Mo YY: MicroRNA regulatory networks and
human disease. Cell Mol Life Sci. 69:3529–3531. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Zamore PD and Haley B: Ribo-gnome: the big
world of small RNAs. Science. 309:1519–1524. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Lu J, Getz G, Miska EA, et al: MicroRNA
expression profiles classify human cancers. Nature. 435:834–838.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Iorio MV, Visone R, Di Leva G, et al:
MicroRNA signatures in human ovarian cancer. Cancer Res.
67:8699–8707. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Olson P, Lu J, Zhang H, et al: MicroRNA
dynamics in the stages of tumorigenesis correlate with hallmark
capabilities of cancer. Genes Dev. 23:2152–2165. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Laios A, O’Toole S, Flavin R, et al:
Potential role of miR-9 and miR-223 in recurrent ovarian cancer.
Mol Cancer. 7:352008. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Rotkrua P, Akiyama Y, Hashimoto Y, Otsubo
T and Yuasa Y: MiR-9 downregulates CDX2 expression in gastric
cancer cells. Int J Cancer. 129:2611–2620. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Moore RG, Chung M, Granai CO, Gajewski W
and Steinhoff MM: Incidence of metastasis to the ovaries from
nongenital tract primary tumors. Gynecol Oncol. 93:87–91. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Guo R, Wu Q, Liu F and Wang Y: Description
of the CD133+ subpopulation of the human ovarian cancer
cell line OVCAR3. Oncol Rep. 25:141–146. 2011.
|
|
11
|
Ma L, Young J, Prabhala H, et al: miR-9, a
MYC/MYCN-activated microRNA, regulates E-cadherin and cancer
metastasis. Nat Cell Biol. 12:247–256. 2010.PubMed/NCBI
|
|
12
|
Chao TF, Zhang Y, Yan XQ, et al: MiR-9
regulates the expression of CBX7 in human glioma. Zhongguo Yi Xue
Ke Xue Yuan Xue Bao. 30:268–274. 2008.(In Chinese).
|
|
13
|
Guo LM, Pu Y, Han Z, et al: MicroRNA-9
inhibits ovarian cancer cell growth through regulation of
NF-kappaB1. FEBS J. 276:5537–5546. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Selcuklu SD, Donoghue MT, Rehmet K, et al:
MicroRNA-9 inhibition of cell proliferation and identification of
novel miR-9 targets by transcriptome profiling in breast cancer
cells. J Biol Chem. 287:29516–29528. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Malpica A, Deavers MT, Lu K, et al:
Grading ovarian serous carcinoma using a two-tier system. Am J Surg
Pathol. 28:496–504. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Kobel M, Kalloger SE, Huntsman DG, et al:
Differences in tumor type in low-stage versus high-stage ovarian
carcinomas. Int J Gynecol Pathol. 29:203–211. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Tan HX, Wang Q, Chen LZ, et al: MicroRNA-9
reduces cell invasion and E-cadherin secretion in SK-Hep-1 cell.
Med Oncol. 27:654–660. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Liu N, Sun Q, Chen J, et al: MicroRNA-9
suppresses uveal melanoma cell migration and invasion through the
NF-κB1 pathway. Oncol Rep. 28:961–968. 2012.PubMed/NCBI
|
|
19
|
Heller G, Weinzierl M, Noll C, et al:
Genome-wide miRNA expression profiling identifies miR-9–3 and
miR-193a as targets for DNA methylation in non-small cell lung
cancers. Clin Cancer Res. 18:1619–1629. 2012.
|
|
20
|
Iorio MV and Croce CM: microRNA
involvement in human cancer. Carcinogenesis. 33:1126–1133. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Lehmann U, Hasemeier B, Christgen M, et
al: Epigenetic inactivation of microRNA gene hsa-mir-9–1 in human
breast cancer. J Pathol. 214:17–24. 2008.
|
|
22
|
Du Y, Liu Z, Gu L, et al: Characterization
of human gastric carcinoma-related methylation of 9 miR CpG islands
and repression of their expressions in vitro and in vivo. BMC
Cancer. 12:2492012. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Lujambio A, Calin GA, Villanueva A, et al:
A microRNA DNA methylation signature for human cancer metastasis.
Proc Natl Acad Sci USA. 105:13556–13561. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Wan HY, Guo LM, Liu T, Liu M, Li X and
Tang H: Regulation of the transcription factor NF-kappaB1 by
microRNA-9 in human gastric adenocarcinoma. Mol Cancer. 9:162010.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Hanahan D and Weinberg RA: The hallmarks
of cancer. Cell. 100:57–70. 2000. View Article : Google Scholar
|
|
26
|
Jemal A, Siegel R, Ward E, Hao Y, Xu J and
Thun MJ: Cancer statistics, 2009. CA Cancer J Clin. 59:225–249.
2009. View Article : Google Scholar
|
|
27
|
Vachon PH: Integrin signaling, cell
survival, and anoikis: distinctions, differences, and
differentiation. J Signal Transduct. 2011:7381372011. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Desiniotis A and Kyprianou N: Significance
of talin in cancer progression and metastasis. Int Rev Cell Mol
Biol. 289:117–147. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Fong YC, Liu SC, Huang CY, et al:
Osteopontin increases lung cancer cells migration via activation of
the alphavbeta3 integrin/FAK/Akt and NF-kappaB-dependent pathway.
Lung Cancer. 64:263–270. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Huang Y, Zhang X, Jiang W, et al:
Discovery of serum biomarkers implicated in the onset and
progression of serous ovarian cancer in a rat model using iTRAQ
technique. Eur J Obstet Gynecol Reprod Biol. 165:96–103. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Vang R, Shihle M and Kurman RJ: Ovarian
low-grade and high-grade serous carcinoma: pathogenesis,
clinicopathologic and molecular biologic features, and diagnostic
problems. Adv Anat Pathol. 16:267–282. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Critchley DR and Gingras AR: Talin at a
glance. J Cell Sci. 121:1345–1347. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Osaki M, Oshimura M and Ito H: PI3K-Akt
pathway: its functions and alterations in human cancer. Apoptosis.
9:667–676. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Hwang YP, Yun HJ, Choi JH, et al:
Suppression of EGF-induced tumor cell migration and matrix
metalloproteinase-9 expression by capsaicin via the inhibition of
EGFR-mediated FAK/Akt, PKC/Raf/ERK, p38 MAPK, and AP-1 signaling.
Mol Nutr Food Res. 55:594–605. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Ren K, Jin H, Bian C, et al: MR-1
modulates proliferation and migration of human hepatoma HepG2 cells
through myosin light chains-2 (MLC2)/focal adhesion kinase
(FAK)/Akt signaling pathway. J Biol Chem. 283:35598–35605. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Sakamoto S, McCann RO, Dhir R and
Kyprianou N: Talin1 promotes tumor invasion and metastasis via
focal adhesion signaling and anoikis resistance. Cancer Res.
70:1885–1895. 2010. View Article : Google Scholar : PubMed/NCBI
|
